Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients
NCT01916200
·
clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
This study was Cancelled Before Active
Conditions
Depressive Disorder
Interventions
DRUG:
Paroxetine CR
Sponsor
GlaxoSmithKline